{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "currency": "USD", "regularMarketChangePercent": 7.2115436, "regularMarketPrice": 2.23, "exchange": "NCM", "shortName": "RenovoRx, Inc.", "longName": "RenovoRx, Inc.", "messageBoardId": "finmb_236111504", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "marketState": "PRE", "firstTradeDateMilliseconds": 1629984600000, "tradeable": false, "cryptoTradeable": false, "priceHint": 4, "regularMarketChange": 0.1500001, "regularMarketTime": 1684180697, "regularMarketDayHigh": 2.26, "regularMarketDayRange": "2.13 - 2.26", "regularMarketDayLow": 2.13, "regularMarketVolume": 15830, "regularMarketPreviousClose": 2.08, "bid": 2.07, "ask": 2.9, "bidSize": 22, "askSize": 22, "fullExchangeName": "NasdaqCM", "financialCurrency": "USD", "regularMarketOpen": 2.19, "averageDailyVolume3Month": 55188, "averageDailyVolume10Day": 15930, "fiftyTwoWeekLowChange": 0.73, "fiftyTwoWeekLowChangePercent": 0.48666668, "fiftyTwoWeekRange": "1.5 - 5.745", "fiftyTwoWeekHighChange": -3.5149999, "fiftyTwoWeekHighChangePercent": -0.6118364, "fiftyTwoWeekLow": 1.5, "fiftyTwoWeekHigh": 5.745, "earningsTimestamp": 1684153800, "earningsTimestampStart": 1684153800, "earningsTimestampEnd": 1684153800, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "epsTrailingTwelveMonths": -0.8, "epsForward": -0.85, "epsCurrentYear": -0.8, "priceEpsCurrentYear": -2.7875, "sharesOutstanding": 10131200, "bookValue": 0.677, "fiftyDayAverage": 3.1506, "fiftyDayAverageChange": -0.92059994, "fiftyDayAverageChangePercent": -0.2921983, "twoHundredDayAverage": 2.627995, "twoHundredDayAverageChange": -0.397995, "twoHundredDayAverageChangePercent": -0.15144435, "marketCap": 30910476, "forwardPE": -2.6235294, "priceToBook": 3.293944, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2021-08-26", "averageAnalystRating": "2.0 - Buy", "displayName": "RenovoRx", "symbol": "RNXT"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "4546 El Camino Real", "address2": "Suite B1", "city": "Los Altos", "state": "CA", "zip": "94022", "country": "United States", "phone": "650 284 4433", "fax": "650 397 4433", "website": "https://renovorx.com", "industry": "Biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "RenovoRx, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapies for the treatment of solid tumors. Its lead product candidate is RenovoGem, a drug and device combination consisting of intra-arterial gemcitabine and RenovoCath that is in Phase III clinical trials for the locally advanced pancreatic cancer. The company was founded in 2009 and is headquartered in Los Altos, California.", "fullTimeEmployees": 9, "companyOfficers": [{"maxAge": 1, "name": "Dr. Ramtin  Agah M.D.", "age": 56, "title": "Founder, Chairman of Board & Chief Medical Officer", "yearBorn": 1966, "fiscalYear": 2022, "totalPay": {"raw": 380035, "fmt": "380.04k", "longFmt": "380,035"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 179000, "fmt": "179k", "longFmt": "179,000"}}, {"maxAge": 1, "name": "Mr. Shaun R. Bagai", "age": 45, "title": "CEO & Director", "yearBorn": 1977, "fiscalYear": 2022, "totalPay": {"raw": 717750, "fmt": "717.75k", "longFmt": "717,750"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 315000, "fmt": "315k", "longFmt": "315,000"}}, {"maxAge": 1, "name": "Ms. Angela Gill Nelms", "age": 46, "title": "Chief Operating Officer", "yearBorn": 1976, "fiscalYear": 2022, "totalPay": {"raw": 456439, "fmt": "456.44k", "longFmt": "456,439"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. James M. Ahlers", "age": 58, "title": "Chief Financial Officer", "yearBorn": 1964, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Leesa  Gentry", "title": "Sr. VP of Clinical Operations", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Ronald B. Kocak CPA", "title": "VP & Controller", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "compensationAsOfEpochDate": 1672444800, "maxAge": 86400}}], "error": null}}